Upcycling Brewers’ Spent Grain: The Development of Muffins and Biomarker Response After Consuming Muffins for 8-Weeks in Healthy Adults From Randomized-Controlled Trial

Brewers’ spent grain (BSG), the most abundant by-product of the brewing industry, consist of malted barley residue leftover from beer production and are rich in fiber and protein. This study examined whether regular consumption of upcycled BSG flour can modulate blood biomarkers of cardiovascular di...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Current developments in nutrition 2020-06, Vol.4 (Supplement_2), p.745-745, Article nzaa052_014
Hauptverfasser: Combest, Shannon, Warren, Cynthia, Patterson, Mindy
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 745
container_issue Supplement_2
container_start_page 745
container_title Current developments in nutrition
container_volume 4
creator Combest, Shannon
Warren, Cynthia
Patterson, Mindy
description Brewers’ spent grain (BSG), the most abundant by-product of the brewing industry, consist of malted barley residue leftover from beer production and are rich in fiber and protein. This study examined whether regular consumption of upcycled BSG flour can modulate blood biomarkers of cardiovascular disease (CVD), glucose homeostasis, inflammation, and body composition in healthy adults. Muffins containing 7.5 g BSG (20% wt: wt flour), 11.2 g BSG (30% wt: wt flour), and 0 g BSG (control) were developed and tested for consumer acceptability on overall liking, appearance, texture, moistness, sponginess, and taste. BSG muffins that maintained mean ratings of 5 or higher on a 9-point hedonic scale were considered acceptable and included in a feeding trial. A single-blind, randomized, placebo-controlled human feeding trial compared consumption of muffins with 12 g BSG (30%) or 0 g BSG daily for 8 weeks. BSG and control muffins were similar in total calories (BSG: 306 kcal, control: 307 kcal) and available carbohydrates (BSG: 51.2 g, control: 52.0 g). Fasting blood was collected for glucose, insulin, and lipid measurements and body composition was assessed using air displacement plethysmography at baseline and 8-weeks. During the 8 weeks of intervention, participants recorded 3-day food logs, 2-day stool logs to monitor changes in bowel movements and symptoms, and daily muffin consumption. Consumer testing (n = 107) found significant differences among appearance (F = 7.728, P = .001) and taste (4.947, P = .008) ratings across all muffins. Control (6.74 ± 1.84) and 20% (6.64 ± 1.90) muffins received higher appearance ratings and higher taste ratings for 20% muffins (7.15 ± 1.72). Additionally, 30% muffins had acceptability. In the feeding trial, 18 participants (26.8 ± 4.0 y) with a BMI of 23.4 ± 3.2 kg/m2completed the study. Systolic blood pressure (BP) (P = .044) and insulin (P = .011) were lower in the BSG group than the control group after consuming study muffins for 8-weeks. There were no significant treatment effects for glucose concentrations or body composition outcomes between test groups or over time. Consuming BSG reduces systolic BP and insulin in healthy adults compared to control muffins. A higher BSG dosage or consuming BSG for a longer duration may be necessary to observe additional clinical endpoints. Moore-Khourie Fund.
doi_str_mv 10.1093/cdn/nzaa052_014
format Article
fullrecord <record><control><sourceid>oup_TOX</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7257626</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><oup_id>10.1093/cdn/nzaa052_014</oup_id><els_id>S247529912308263X</els_id><sourcerecordid>10.1093/cdn/nzaa052_014</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2674-c556974495a0c5eff46c43ea29366109e0de3d933a67b547668d4706d0728d9c3</originalsourceid><addsrcrecordid>eNqNkcFO3DAQhqOKSkWUc68-I4V1Esdec0BalgKVqCrBoh4tY49ZF8eO7GSr5cRr8Ap9rD5JvdoW0QMSp5mx__-TZv6i-FThwwrzZqK0n_gHKXFbC1yRd8VuTVhb1pxXOy_6D8V-Sj8wxhXnnGK-W_y66dVaOevv0EmEnxDT78cndN2DH9B5lNYfocUS0CmswIW-2zwHg76OxlifkPQandjQyXgPEV1B6oNPgGZmyOM892O3If-TmxDRtPwOcJ-Q9egCpBuWazTToxsSOouhQ1cZGTr7ALrM_iEG50CjRbTSfSzeG-kS7P-te8XN2efF_KK8_Hb-ZT67LFVNGSlV21LOCOGtxKoFYwhVpAFZ84bSfCzAGhrNm0ZSdtsSRulUE4apxqyeaq6aveJ4y-3H2w60yjtH6UQfbd5zLYK04v8fb5fiLqwEq1tGa5oBky1AxZBSBPPsrbDYxCVyXOJFXNlxsHWEsX-DmG_FkI-wshBFUha8Am0jqEHoYF_1_gFcqbBy</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Upcycling Brewers’ Spent Grain: The Development of Muffins and Biomarker Response After Consuming Muffins for 8-Weeks in Healthy Adults From Randomized-Controlled Trial</title><source>Oxford Journals Open Access</source><creator>Combest, Shannon ; Warren, Cynthia ; Patterson, Mindy</creator><creatorcontrib>Combest, Shannon ; Warren, Cynthia ; Patterson, Mindy</creatorcontrib><description>Brewers’ spent grain (BSG), the most abundant by-product of the brewing industry, consist of malted barley residue leftover from beer production and are rich in fiber and protein. This study examined whether regular consumption of upcycled BSG flour can modulate blood biomarkers of cardiovascular disease (CVD), glucose homeostasis, inflammation, and body composition in healthy adults. Muffins containing 7.5 g BSG (20% wt: wt flour), 11.2 g BSG (30% wt: wt flour), and 0 g BSG (control) were developed and tested for consumer acceptability on overall liking, appearance, texture, moistness, sponginess, and taste. BSG muffins that maintained mean ratings of 5 or higher on a 9-point hedonic scale were considered acceptable and included in a feeding trial. A single-blind, randomized, placebo-controlled human feeding trial compared consumption of muffins with 12 g BSG (30%) or 0 g BSG daily for 8 weeks. BSG and control muffins were similar in total calories (BSG: 306 kcal, control: 307 kcal) and available carbohydrates (BSG: 51.2 g, control: 52.0 g). Fasting blood was collected for glucose, insulin, and lipid measurements and body composition was assessed using air displacement plethysmography at baseline and 8-weeks. During the 8 weeks of intervention, participants recorded 3-day food logs, 2-day stool logs to monitor changes in bowel movements and symptoms, and daily muffin consumption. Consumer testing (n = 107) found significant differences among appearance (F = 7.728, P = .001) and taste (4.947, P = .008) ratings across all muffins. Control (6.74 ± 1.84) and 20% (6.64 ± 1.90) muffins received higher appearance ratings and higher taste ratings for 20% muffins (7.15 ± 1.72). Additionally, 30% muffins had acceptability. In the feeding trial, 18 participants (26.8 ± 4.0 y) with a BMI of 23.4 ± 3.2 kg/m2completed the study. Systolic blood pressure (BP) (P = .044) and insulin (P = .011) were lower in the BSG group than the control group after consuming study muffins for 8-weeks. There were no significant treatment effects for glucose concentrations or body composition outcomes between test groups or over time. Consuming BSG reduces systolic BP and insulin in healthy adults compared to control muffins. A higher BSG dosage or consuming BSG for a longer duration may be necessary to observe additional clinical endpoints. Moore-Khourie Fund.</description><identifier>ISSN: 2475-2991</identifier><identifier>EISSN: 2475-2991</identifier><identifier>DOI: 10.1093/cdn/nzaa052_014</identifier><language>eng</language><publisher>Elsevier Inc</publisher><subject>Food Science and Nutrition</subject><ispartof>Current developments in nutrition, 2020-06, Vol.4 (Supplement_2), p.745-745, Article nzaa052_014</ispartof><rights>2020 American Society for Nutrition.</rights><rights>Copyright © The Author(s) on behalf of the American Society for Nutrition 2020. 2020</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c2674-c556974495a0c5eff46c43ea29366109e0de3d933a67b547668d4706d0728d9c3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7257626/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7257626/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,864,885,1604,27924,27925,53791,53793</link.rule.ids><linktorsrc>$$Uhttps://dx.doi.org/10.1093/cdn/nzaa052_014$$EView_record_in_Oxford_University_Press$$FView_record_in_$$GOxford_University_Press</linktorsrc></links><search><creatorcontrib>Combest, Shannon</creatorcontrib><creatorcontrib>Warren, Cynthia</creatorcontrib><creatorcontrib>Patterson, Mindy</creatorcontrib><title>Upcycling Brewers’ Spent Grain: The Development of Muffins and Biomarker Response After Consuming Muffins for 8-Weeks in Healthy Adults From Randomized-Controlled Trial</title><title>Current developments in nutrition</title><description>Brewers’ spent grain (BSG), the most abundant by-product of the brewing industry, consist of malted barley residue leftover from beer production and are rich in fiber and protein. This study examined whether regular consumption of upcycled BSG flour can modulate blood biomarkers of cardiovascular disease (CVD), glucose homeostasis, inflammation, and body composition in healthy adults. Muffins containing 7.5 g BSG (20% wt: wt flour), 11.2 g BSG (30% wt: wt flour), and 0 g BSG (control) were developed and tested for consumer acceptability on overall liking, appearance, texture, moistness, sponginess, and taste. BSG muffins that maintained mean ratings of 5 or higher on a 9-point hedonic scale were considered acceptable and included in a feeding trial. A single-blind, randomized, placebo-controlled human feeding trial compared consumption of muffins with 12 g BSG (30%) or 0 g BSG daily for 8 weeks. BSG and control muffins were similar in total calories (BSG: 306 kcal, control: 307 kcal) and available carbohydrates (BSG: 51.2 g, control: 52.0 g). Fasting blood was collected for glucose, insulin, and lipid measurements and body composition was assessed using air displacement plethysmography at baseline and 8-weeks. During the 8 weeks of intervention, participants recorded 3-day food logs, 2-day stool logs to monitor changes in bowel movements and symptoms, and daily muffin consumption. Consumer testing (n = 107) found significant differences among appearance (F = 7.728, P = .001) and taste (4.947, P = .008) ratings across all muffins. Control (6.74 ± 1.84) and 20% (6.64 ± 1.90) muffins received higher appearance ratings and higher taste ratings for 20% muffins (7.15 ± 1.72). Additionally, 30% muffins had acceptability. In the feeding trial, 18 participants (26.8 ± 4.0 y) with a BMI of 23.4 ± 3.2 kg/m2completed the study. Systolic blood pressure (BP) (P = .044) and insulin (P = .011) were lower in the BSG group than the control group after consuming study muffins for 8-weeks. There were no significant treatment effects for glucose concentrations or body composition outcomes between test groups or over time. Consuming BSG reduces systolic BP and insulin in healthy adults compared to control muffins. A higher BSG dosage or consuming BSG for a longer duration may be necessary to observe additional clinical endpoints. Moore-Khourie Fund.</description><subject>Food Science and Nutrition</subject><issn>2475-2991</issn><issn>2475-2991</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNqNkcFO3DAQhqOKSkWUc68-I4V1Esdec0BalgKVqCrBoh4tY49ZF8eO7GSr5cRr8Ap9rD5JvdoW0QMSp5mx__-TZv6i-FThwwrzZqK0n_gHKXFbC1yRd8VuTVhb1pxXOy_6D8V-Sj8wxhXnnGK-W_y66dVaOevv0EmEnxDT78cndN2DH9B5lNYfocUS0CmswIW-2zwHg76OxlifkPQandjQyXgPEV1B6oNPgGZmyOM892O3If-TmxDRtPwOcJ-Q9egCpBuWazTToxsSOouhQ1cZGTr7ALrM_iEG50CjRbTSfSzeG-kS7P-te8XN2efF_KK8_Hb-ZT67LFVNGSlV21LOCOGtxKoFYwhVpAFZ84bSfCzAGhrNm0ZSdtsSRulUE4apxqyeaq6aveJ4y-3H2w60yjtH6UQfbd5zLYK04v8fb5fiLqwEq1tGa5oBky1AxZBSBPPsrbDYxCVyXOJFXNlxsHWEsX-DmG_FkI-wshBFUha8Am0jqEHoYF_1_gFcqbBy</recordid><startdate>202006</startdate><enddate>202006</enddate><creator>Combest, Shannon</creator><creator>Warren, Cynthia</creator><creator>Patterson, Mindy</creator><general>Elsevier Inc</general><general>Oxford University Press</general><scope>6I.</scope><scope>AAFTH</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope></search><sort><creationdate>202006</creationdate><title>Upcycling Brewers’ Spent Grain: The Development of Muffins and Biomarker Response After Consuming Muffins for 8-Weeks in Healthy Adults From Randomized-Controlled Trial</title><author>Combest, Shannon ; Warren, Cynthia ; Patterson, Mindy</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2674-c556974495a0c5eff46c43ea29366109e0de3d933a67b547668d4706d0728d9c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Food Science and Nutrition</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Combest, Shannon</creatorcontrib><creatorcontrib>Warren, Cynthia</creatorcontrib><creatorcontrib>Patterson, Mindy</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Current developments in nutrition</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Combest, Shannon</au><au>Warren, Cynthia</au><au>Patterson, Mindy</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Upcycling Brewers’ Spent Grain: The Development of Muffins and Biomarker Response After Consuming Muffins for 8-Weeks in Healthy Adults From Randomized-Controlled Trial</atitle><jtitle>Current developments in nutrition</jtitle><date>2020-06</date><risdate>2020</risdate><volume>4</volume><issue>Supplement_2</issue><spage>745</spage><epage>745</epage><pages>745-745</pages><artnum>nzaa052_014</artnum><issn>2475-2991</issn><eissn>2475-2991</eissn><abstract>Brewers’ spent grain (BSG), the most abundant by-product of the brewing industry, consist of malted barley residue leftover from beer production and are rich in fiber and protein. This study examined whether regular consumption of upcycled BSG flour can modulate blood biomarkers of cardiovascular disease (CVD), glucose homeostasis, inflammation, and body composition in healthy adults. Muffins containing 7.5 g BSG (20% wt: wt flour), 11.2 g BSG (30% wt: wt flour), and 0 g BSG (control) were developed and tested for consumer acceptability on overall liking, appearance, texture, moistness, sponginess, and taste. BSG muffins that maintained mean ratings of 5 or higher on a 9-point hedonic scale were considered acceptable and included in a feeding trial. A single-blind, randomized, placebo-controlled human feeding trial compared consumption of muffins with 12 g BSG (30%) or 0 g BSG daily for 8 weeks. BSG and control muffins were similar in total calories (BSG: 306 kcal, control: 307 kcal) and available carbohydrates (BSG: 51.2 g, control: 52.0 g). Fasting blood was collected for glucose, insulin, and lipid measurements and body composition was assessed using air displacement plethysmography at baseline and 8-weeks. During the 8 weeks of intervention, participants recorded 3-day food logs, 2-day stool logs to monitor changes in bowel movements and symptoms, and daily muffin consumption. Consumer testing (n = 107) found significant differences among appearance (F = 7.728, P = .001) and taste (4.947, P = .008) ratings across all muffins. Control (6.74 ± 1.84) and 20% (6.64 ± 1.90) muffins received higher appearance ratings and higher taste ratings for 20% muffins (7.15 ± 1.72). Additionally, 30% muffins had acceptability. In the feeding trial, 18 participants (26.8 ± 4.0 y) with a BMI of 23.4 ± 3.2 kg/m2completed the study. Systolic blood pressure (BP) (P = .044) and insulin (P = .011) were lower in the BSG group than the control group after consuming study muffins for 8-weeks. There were no significant treatment effects for glucose concentrations or body composition outcomes between test groups or over time. Consuming BSG reduces systolic BP and insulin in healthy adults compared to control muffins. A higher BSG dosage or consuming BSG for a longer duration may be necessary to observe additional clinical endpoints. Moore-Khourie Fund.</abstract><pub>Elsevier Inc</pub><doi>10.1093/cdn/nzaa052_014</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier ISSN: 2475-2991
ispartof Current developments in nutrition, 2020-06, Vol.4 (Supplement_2), p.745-745, Article nzaa052_014
issn 2475-2991
2475-2991
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7257626
source Oxford Journals Open Access
subjects Food Science and Nutrition
title Upcycling Brewers’ Spent Grain: The Development of Muffins and Biomarker Response After Consuming Muffins for 8-Weeks in Healthy Adults From Randomized-Controlled Trial
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-20T19%3A07%3A52IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-oup_TOX&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Upcycling%20Brewers%E2%80%99%20Spent%20Grain:%20The%20Development%20of%20Muffins%20and%20Biomarker%20Response%20After%20Consuming%20Muffins%20for%208-Weeks%20in%20Healthy%20Adults%20From%20Randomized-Controlled%20Trial&rft.jtitle=Current%20developments%20in%20nutrition&rft.au=Combest,%20Shannon&rft.date=2020-06&rft.volume=4&rft.issue=Supplement_2&rft.spage=745&rft.epage=745&rft.pages=745-745&rft.artnum=nzaa052_014&rft.issn=2475-2991&rft.eissn=2475-2991&rft_id=info:doi/10.1093/cdn/nzaa052_014&rft_dat=%3Coup_TOX%3E10.1093/cdn/nzaa052_014%3C/oup_TOX%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rft_oup_id=10.1093/cdn/nzaa052_014&rft_els_id=S247529912308263X&rfr_iscdi=true